Founded in 1967 in Singapore, Xepa has grown and evolved at the cutting edge of the industry. From our modest first years when Xepa Laboratories Pte. Ltd. produced a limited range of pharmaceutical products in a small flatted factory, we have relocated twice to larger manufacturing plants in Melaka, Malaysia. Today, Xepa is the leading manufacturer of off-patent pharmaceuticals in Malaysia.

The Xepa manufacturing site in Cheng Industrial Estate, Melaka of 195,000 sq ft built-up area consists of 7 buildings including laboratories, liquids production plant, solids production plants, warehouse and offices spread over a 10-acre site.

The latest addition for liquid preparations on this site was completed in 4th quarter 2007, whilst the building of solid production plant (an extension of the current solid production plant) was completed in 2010.

Xepa’s product line, which includes tablets, capsules, powders, oral liquids, creams, ointments and sterile eye drops, are exported to more than a dozen countries around the world such as Hong Kong, Japan, Singapore and countries in Africa and the ASEAN region.

Contract Manufacturing

In Xepa, we are committed to uphold the highest standards in all aspects of our business. Our quality is backed by 50 years of experience in this industry, as exemplified by the certification of our production and laboratory facilities for ISO 17025, ISO 9001, ISO 13485 and EU GMP compliance. Our recent investments and expansions on the liquid production plant and solid production plant make it possible for continuous business growth to meet the needs and demands of our customers.

Product Development

Xepa’s focus on building human capital produce competent and qualified personnel in the research arena. Our experts will be able to advise you in the area of idea generation, product design and detail engineering. Our consultation may cover any stage in the lifecycle of the product to provide customized solutions for client’s needs and requirements.